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a b s t r a c t
The costs of delivering routine immunization services in India vary widely across facilities, districts and
states. Understanding the factors influencing this cost variation could help predict future immunization
costs and suggest approaches for improving the efficiency of service provision.
We examined determinants of facility cost for immunization services based on a nationally
representative sample of sub-centres and primary health centres (99 and 89 facilities, respectively) by
regressing logged total facility costs, both including and excluding vaccine cost, against several
explanatory variables. We used a multi-level regression model to account for the multi-stage sampling
design, including state- and district-level random effects.
We found that facility costs were significantly associated with total doses administered, type of facility,
salary of the main vaccinator, number of immunization sessions, and the distance of the facility from the
nearest cold chain point.
Use of pentavalent vaccine by the state was an important determinant of total facility cost including
vaccine cost. India is introducing several new vaccines including some supported by Gavi. Therefore,
the government will have to ensure that additional resources will be made available after the support
from Gavi ceases.
 2018 The Authors. Published by Elsevier Ltd. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).
1. Introduction
The costs of delivering routine immunization services vary
widely across facilities within countries and across countries
[1–4]. Understanding the reasons for such variation can provide
insights into site operations and help improve programme
efficiency. Recently, under the EPI Costing and Financing (EPIC)
project, a few studies have investigated the cost drivers of routine
immunization programmes [5,6]; however, there is clearly a dearth
of such evidence in large countries like India. Because immuniza-
tion programmes differ across countries based on distribution of
health care services, population characteristics, and vaccine sched-
ules, country-level information on costs and cost determinants is
important.
India’s national immunization programme was introduced in
1978 following the success of smallpox eradication [7]. The
programme is the largest in the world and covers a birth cohort
of 26 million infants for eight vaccine-preventable diseases:
diphtheria, whooping cough, tetanus, poliomyelitis, tuberculosis,
measles, hepatitis B, and Haemophilus influenzae type B (Hib)
(which causes pneumonia and meningitis). The programme also
provides vaccination for Japanese encephalitis in areas affected
by the disease. Recently, a vaccine against rotavirus has been
introduced in nine states, and pneumococcal vaccine has been
introduced in a cohort of three states with a plan to rapidly scale
up in other cohorts or states.
The total expenditure for India’s immunization programme as
reported in the comprehensive multi-year plan for immunization
(cMYP), was US$718 million in 2012–13 [8], and a recent study
on routine immunization costs showed substantial variation in
unit costs across facilities, districts and states [9]. During 2013–
14, the weighted average state-level cost per dose delivered varied
from US$1.31 to US$2.79 including the vaccine cost, while the cost
per child vaccinated with the third dose of diphtheria, pertussis,
tetanus (DPT) vaccine (a proxy for full immunization) varied from
US$19.11to US$33.13 including the vaccine cost. In this study, we
examine the factors underlying these cost variations and suggest
approaches to improving the efficiency of service provision.
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2. Methods
As part of the India immunization costing study, data on immu-
nization service costs were collected from 255 government health
facilities of different types across seven states, using a multi-stage
cluster sampling design [9]. India’s 29 states were stratified into six
levels of development based on indicators such as female literacy
rate, full immunization coverage rate, infant mortality rate, and
per capita income. The states were further classified into six
regions – north, northeast, east, central, south and west. To ensure
a nationally representative sample, the study used stratified pur-
poseful sampling to select seven states representing all six levels
of development and all six regions. Study states included Punjab
(north); Meghalaya (northeast); Bihar and West Bengal (east);
Uttar Pradesh (central); Kerala (south); and Gujarat (west).
Although Bihar and Uttar Pradesh were at the same level of devel-
opment, both were selected as they have high priority for improv-
ing immunization coverage.
The costing study had calculated the number of health facilities
that would be required to estimate the mean cost per fully vacci-
nated child within a margin of error of US$3 with a 95% confidence
interval in each of the selected states, after accounting for the
multi-stage cluster sampling design. In the calculation, the stan-
dard deviation of the cost per fully immunized child was assumed
to be US$8 or US$10, depending on the state under consideration.
The two-stage cluster sampling design was accounted for by mul-
tiplying the sample size obtained under simple random sampling
by the design effect of 1.2.
Because of time and resource constraints, the researchers
reduced the number of health facilities in Uttar Pradesh and Bihar.
The study comprised 24 health facilities each from Uttar Pradesh
and Bihar; 48 health facilities each from Gujarat, Punjab and West
Bengal; 33 from Kerala; and 30 fromMeghalaya, resulting in a total
of 255 facilities across seven states [9]. To ensure representative-
ness at the state level, the study used a stratified sampling design
to select health facilities in each state. Districts in the selected
states were divided into three or four strata based on the scores
obtained from four district-level indicators: number of children
aged 0–6 years, proportion of households in rural areas, proportion
of children aged 0–6 years receiving full immunization, and num-
ber of health facilities per 1000 children. One district from each
stratum was randomly selected using a computer application that
employs random number generator. In each district, two blocks
(sub-districts) were selected using purposive sampling based on
two indicators: (1) the percentage of scheduled caste or scheduled
tribe members in the population; and (2) the female literacy rate.
The blocks were selected to cover the lower and upper extremes of
these indicators. Each block typically has one community health
centre (CHC),2 which was selected for inclusion in this study. In
addition, two or three primary health centres (PHCs) associated with
the CHC, as well as one or two sub-centres (SCs) under the selected
PHCs were randomly selected. The final sample comprised 255
health facilities of four different types: 44 CHCs, 89 PHCs, 99 SCs,
and 23 post-partum (PP) units at the district hospitals of the selected
districts. A flow chart (Fig. 1) summarizes the sampling strategy fol-
lowed within a selected state.
Economic costs of routine immunization were estimated from a
government provider perspective and based on an approach that
adapted a standardized method used for immunization costing
studies (Common Approach) [11]. Total facility cost was the sum
of personnel, capital costs, and all other recurrent expenses. Per-
sonnel costs were estimated based on salaries and allowances for
various categories of staff involved in immunization and the time
staff spent on activities related to immunization, which included
conducting immunization sessions, transporting vaccines, keeping
records, maintaining cold chains, monitoring and supervision,
preparing microplans, and attending trainings and meetings. Cap-
ital costs included the annualized discounted value of cold chain
equipment, vehicles and buildings. Costs for shared vehicles were
based on the number of days a vehicle was used for immunization
activities, while building costs were derived from the number of
days a building was used for immunizations and the proportion
of the building used. Other recurrent expenses were costs of vacci-
nes and supplies, expenditures on trainings, meetings, vaccine
transport, waste management, cold chain maintenance, printing,
traveling to immunization sessions, and incentives, along with
overhead expenses (e.g., for electricity and water). Overhead
expenses were distributed to immunization and cold chain rooms
based on share of space used for immunization.
Trained data collection teams visited each facility from October
2014 to October 2015. Data were gathered from financial reports,
monthly immunization reports, immunization registers showing
the total vaccines administered, and vaccine stock and issue regis-
ters. To determine person-time spent on immunization activities,
the team interviewed staff involved in these activities. Data were
also collected on possible determinants of immunization costs,
including number of sessions and distance from the nearest cold
chain point. Wastage rates for each vaccine at the vaccinator level
were calculated using doses used and doses administered [9]. Total
costs were estimated for one fiscal year, April 2013 to March 2014,
and results were reported in 2013 US dollars. Throughout the
Fig. 1. Flow chart describing sampling strategy within a selected state: same flow
chart is applicable for all seven states. Note: CHC: community health centre; PHC:
primary health centre; SC: sub-centre.
2 In India’s rural health system, SCs are the most peripheral and the first contact
point between the primary health care system and the community. Each PHC is a
four- to six-bed referral unit for six SCs. CHC is a 30-bed hospital or referral unit of
four PHCs with specialized services [10]. In each district, there is generally one district
hospital; immunization activities are conducted in each district hospital’s post-
partum unit.
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paper, we used an exchange rate of US$1 = INR 58, the average
exchange rate during 2013.
To understand the determinants of cost, in addition to primary
data collection, we extracted block-level sociodemographic data
from the 2011 census of India (the latest census data available).
We collected data on variables including proportion of females
who are literate, proportion of households belonging to scheduled
castes or scheduled tribes, and proportion of households located in
rural areas. Studies conducted in India had shown that immuniza-
tion coverage is affected by sociodemographic characteristics such
as literacy, caste, location and wealth index. Complete vaccination
of a child is more likely if the mother is literate and the household
belongs to a higher wealth quintile [12–14]. To estimate wealth,
we extracted variables related to availability of facilities and asset
possession of households and constructed a block-level wealth
index using principal component analysis (PCA). The variables
included the proportion of households in a given block reporting
each of a wide range of amenities (tap water, electricity, a latrine,
an improved latrine, non-use of solid fuel, banking services, a radio,
a television, a computer, a phone, a two-wheel vehicle, a four-
wheel vehicle). After deriving the principal components using
PCA, we found that the first principal component explained 64%
of the total variability. We therefore used the first principal compo-
nent as the block-level wealth index. Based on the wealth index,
we categorized the study blocks into quintiles: poorest, poorer,
middle, richer, and richest.
2.1. Cost determinants model
We examined determinants of facility cost for immunization
services provided by the SCs and PHCs by regressing logged total
facility costs against several explanatory variables. For the main
analysis, we considered total facility cost excluding vaccine cost
as the outcome variable, as vaccine prices are fixed nationally
and not affected by health facility performance. We adopted a mul-
tilevel model to account for the complex sample design with state-
and district-level random effects, and we examined the relation-
ship between facility-level total cost and explanatory variables at
the facility, block, district and state levels. We usedMLwiN (version
2.32) for fitting the multilevel models [15].
Our three-level regression model is
yijk ¼ b0 þ bXijk þ f k þ v jk þ ijk
where the outcome variable yijk is the logged total immunization
cost excluding the vaccine cost for the ith health facility in the jth
district in state k. The error term ijk is normally distributed with
mean 0 and variance r2. Xijk represents the facility-, block-,
district- and state-level variables. f k and v jk are the random inter-
cepts attributable to states and districts, respectively. The state-
and district-level random intercepts are normally distributed with
means 0 variances r2f and r2v , respectively, and are independent
of one another and of the error term.
We fitted a series of regression models starting with the null
model without any fixed effects and only random components,
and then we added ‘quantity’ (log doses administered) as the
explanatory variable. The successive models had an increasing
number of explanatory variables, including the health system level
of the facility (health facility type: SC or PHC); other facility char-
acteristics related to immunization activities (log distance from the
nearest cold chain point and log number of immunization ses-
sions); a proxy price measure based on the average salary of the
main vaccinator; and, as a crude quality measure, the logged ratio
of third doses of DPT vaccine to total doses administered. State-
level per capita income in 2013–14 was considered as a crude
index of price differences among states [16] and was included as
a state-level covariate.
The selection of these explanatory variables was motivated by
an earlier study of immunization delivery cost determinants in
six countries (Benin, Ghana, Honduras, Moldova, Uganda and Zam-
bia), which reported relationships betweenmany of these variables
and total facility cost [17]. As India immunization costing study
adopted the same costing methodology used in these six countries
(Common Approach), we included similar explanatory variables in
the model.
The number of health facilities per 1000 children and the pro-
portion of institutional deliveries in the district were used as prox-
ies for availability of health services at the district level. To account
for variations in sociodemographic and economic characteristics
across the sampled blocks, we included several block-level vari-
ables — proportion of females who are literate, proportion of house-
holds belonging to a scheduled caste or scheduled tribe, proportion
of households that are rural, and, lastly, the block’s wealth quintile.
Because the regressions used logged costs, the regression coeffi-
cients are difficult to interpret directly.We therefore calculated first
differences to demonstrate the implications of the regression
results. We used simulation to estimate first differences and 95%
confidence intervals (CI) for the predictors that were found to be
significantly associated with the total cost. For continuous predic-
tors, first differences were calculated to represent the difference
between the 25th and 75th percentiles for each predictor.
Descriptive statistics of the explanatory variables are presented
in Table 1.
We decided against including CHCs and PP units in the regres-
sion. CHC operations differed substantially across states. For exam-
ple, CHCs were the immunization planning units at the sub-district
level for all study states except Gujarat. PHCs were the planning
units in Gujarat, and CHCs there had very limited immunization
activities. Hence, we dropped Gujarat CHCs, which reduced our
sample size for a separate regression for CHCs. We did not combine
PP units with SCs and PHCs because of the PP units’ different mode
of operation. Hence, our regression results were based on combin-
ing data across 99 SCs and 89 PHCs.
3. Sensitivity analyses
We ran a separate regression for total facility costs including
vaccine cost. In this model, in addition to state-level per capita
income, we considered the use of pentavalent vaccine in a state
as another predictor. Pentavalent vaccine was introduced in a
phased manner in India. During the study period, two sampled
states (Gujarat and Kerala) used pentavalent vaccine, while the
other five states used DPT and hepatitis B vaccines. Use of pentava-
lent vaccine in a state probably contributed to cost variations across
states and was considered as a predictor (Appendix Table S1).
In the main analysis, we conducted pooled regression analyses
combining data from both SCs and PHCs in a single regression
model. It is possible that the effects of different cost determinants
vary by facility type, and as a robustness check we fitted separate
regressions for SCs and PHCs. Although the effect size for doses
administered on total facility cost was greater for SCs than for
PHCs, most of estimated regression coefficients from these sepa-
rate regressions were similar in magnitude and in the same direc-
tion (Appendix Table S2). We decided against running separate
regressions for CHCs and PP units for reasons explained earlier.
4. Results
We present the regression coefficients from the final regression,
including all explanatory variables, in Table 2. We found that total
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doses administered, type of facility (SC or PHC), salary of the main
vaccinator and the number of immunization sessions were signifi-
cantly associated with total facility cost excluding vaccine cost. On
calculating first differences, we found that for 1 interquartile range
increase in number of doses (1032 doses more), number of immu-
nization sessions (42 sessions more) and salary of the main vacci-
nator (US$2228 higher), the average cost increased by US$239 (95%
CI = US$46 to US$453), US$1062 (95% CI = US$713 to US$1439) and
US$732 (95% CI = US$501 to US$982), respectively. The cost at sub-
centres was found to be significantly lower compared to the cost at
primary health centres by US$1934 (95% CI = US$1573 to US
$2332).
Higher female literacy rates in a block were found to be margin-
ally associated with lower facility costs net vaccine costs. Control-
ling for other predictors, rural health facilities had lower costs than
urban ones, and health facilities in wealthier blocks had lower
costs than did those in poorer blocks. The other block- and
district-level variables that we considered were not found to be
significantly associated with facility cost excluding vaccine cost.
Per capita income across the study states varied widely. In
2013–14, Bihar had the lowest per capita income, at US$538, and
Gujarat had the highest, at US$1842. A 25% increase in state per
capita income was associated with an increase in total facility cost
by US$373 (95% CI = US$112 to US$675).
The sensitivity analysis conducted using facility cost including
vaccine cost as the outcome variable produced similar findings.
At the facility level, the total doses administered, the type of facil-
ity (SC or PHC), the salary of the main vaccinator, and the number
of immunization sessions were significantly associated with the
total facility cost. The distance of a facility from the nearest cold
chain point was significantly associated with costs calculated,
including vaccine costs.
5. Discussion
This study presents the determinants of routine immunization
programme costs in India using data from 99 SCs and 89 PHCs
across seven states. From the cost-determinant model, we found
that the main determinants of total facility costs were total doses
administered; the type of facility (SC or PHC); the salary of the
main vaccinator; the number of immunization sessions; and the
distance of the facility from the nearest cold chain point. The
studies in Benin and Ghana found doses administered as signifi-
cant determinants of cost; however, salary was not significantly
associated [5,6]. The multi country study on determinants of
immunization costs also found that higher health facility level
was associated with higher costs probably because of differences
in availability of staff and infrastructure [17]. Higher service
volume was significantly associated with lower average cost while
greater distance for vaccine collection was associated with higher
facility cost.
Table 1
Descriptive statistics of explanatory variables.
Bihar Gujarat Kerala Meghalaya Punjab Uttar
Pradesh
West
Bengal
Sub-centre
Number of facilities 9 20 12 9 20 10 19
Total facility cost with vaccine, median (IQR) (US$) 2966
(764)
2776
(961)
1468
(318)
1749
(817)
2820
(655)
2628 (426) 2249
(63 1)
Total facility cost without vaccine, median (IQR) (US$) 2271
(831)
1451
(477)
1346
(301)
1581
(888)
2570
(658)
2272 (399) 1987
(540)
Doses administered, median (IQR) 2338
(582)
1372
(744)
207 (56) 1340
(461)
1368
(370)
1748 (890) 1228
(513)
Main vaccinator’s salary, median (IQR) (US$) 5627
(3694)
4567
(2177)
5087
(2221)
4450
(1463)
7144
(1433)
7972
(2617)
6319
(1195)
Distance from nearest cold chain point, median (IQR) (km) 8 (8) 10 (9) 3 (1) 10 (6) 9 (10) 13 (8) 9 (8)
Number of immunization sessions, median (IQR) 111 (26) 48 (17) 16 (12) 81 (29) 48 (14) 77 (26) 38 (10)
Proportion of DPT3 doses to total doses, average (SD) 0.07
(0.01)
0.09
(0.01)
0.11
(0.01)
0.08 (0.01) 0.07
(0.01)
0.08 (0.02) 0.07
(0.01)
Primary Health Centre
Number of facilities 7 18 12 13 16 6 17
Total facility cost with vaccine, median (IQR) (US$) 3022
(3364)
6923
(2940)
7194
(1914)
6328
(950)
3850
(2399)
4399 (585) 3882
(1584)
Total facility cost without vaccine, median (IQR) (US$) 2731
(3165)
5490
(2478)
6661
(1488)
6100
(1112)
3590
(2348)
3970 (612) 3539
(1587)
Doses administered, median (IQR) 2438
(2027)
1280
(1135)
896 (794) 2485
(2074)
1388
(545)
2509 (539) 1671
(812)
Main vaccinator’s salary, median (IQR) (US$) 6376
(2020)
4637
(2363)
5476
(1567)
5608
(1283)
7120
(2822)
8237 (751) 6586
(2198)
Distance from nearest cold chain point, median (IQR) (km) 15 (5) 30 (18) 7 (9) 44 (18) 12 (11) 12 (6) 10 (8)
Number of immunization sessions, median (IQR) 106 (22) 64 (33) 52 (9) 136 (74) 48 (15) 79 (25) 36 (17)
Proportion of DPT3 doses to total doses, average (SD) 0.07
(0.01)
0.09
(0.01)
0.12
(0.02)
0.08 (0.01) 0.07
(0.01)
0.07 (0.01) 0.07
(0.01)
State, district and sub-district level variables
Pentavalent vaccine administered in study states No Yes Yes No No No No
Per capita income of study states, 2013–14 (US$) 538 1842 1790 1061 1597 625 1208
Health facilities per 1000 children in study districts (average) 0.58 1.52 2.04 0.93 1.82 0.75 1.07
Percentage of institutional delivery in districts (average) 66 89 100 50 91 72 78
Female literacy rate in sub-districts, median (IQR) 44 (6) 60 (14) 87 (4) 58 (7) 56 (14) 49 (5) 56 (15)
Percentage of schedule caste/schedule tribe population in sub-districts,
median (IQR)
18 (3) 13 (60) 9 (9) 97 (5) 31 (11) 16 (5) 27 (39)
Percentage of rural population in sub-districts, median (IQR) 76 (25) 84 (32) 54 (54) 100 (13) 71 (23) 84 (20) 88 (21)
Proportion of sub-districts in lowest wealth quintile 0.33 0.25 0.00 0.50 0.00 0.00 0.37
IQR = interquartile range; SD = standard deviation.
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Vaccine wastage rates are expected to be an important determi-
nant of cost; however, we could not consider this variable in our
regression model. We calculated the vaccine wastage rate at the
vaccinator level for all antigens by subtracting doses administered
from doses used, divided by doses used. Where an open-vial policy
was applicable, we considered returned doses when we calculated
wastage rates. Wastage rates for vaccines were calculated for 164
of the 255 vaccinators; for the remaining 91, we relied on the
wastage rates used in India’s comprehensive multi-year plan for
immunization (cMYP), because data were not available [9]. Hence,
for some facilities, the wastage rate used was not actual. Because of
the measurement error in wastage rate, we dropped this variable
from our regression model. The multi-country study on determi-
nants of immunization cost also could not include vaccine wastage
rate as an explanatory variable because of data limitations [17].
We wanted to include immunization coverage as one of the
explanatory variables, as we expect coverage will be a determinant
of total cost. However, several sampled facilities reported more
than 100% DPT3 coverage rate, indicating non-trivial measurement
errors. For this reason, we dropped this variable as well. The multi-
country study found a negative coefficient for coverage rate. It is
expected that costs will increase with coverage as improving cov-
erage will require more efforts for vaccinating hard-to-reach chil-
dren. No firm conclusions were drawn on the reason of such
negative relationship because of mismeasurement of reported cov-
erage [17].
The present study has several limitations. First, for calculating
cost per dose, we used data reported by administrators, and the
quality of these data is questionable. India’s immunization costing
study also noted several data reporting errors at all levels [9]. How-
ever, as there is no other source of such data, we had to rely on this
source. Second, we did not consider two potentially important
variables in our regression model, vaccine wastage rate and immu-
nization coverage rate. These variables were not considered in our
regression model because of missing data and poor record keeping.
Further, greater completion of the vaccination schedule (proxied
by the ratio of DPT3 to total doses) did not show any significant
relationship to cost, despite having been found to have a strong
positive relationship with cost in a pooled analysis of six countries
[17]. Poor record keeping systems in India could be the reason for
this. This analysis advocates for better record keeping in the Indian
context. Providing more training of staff and introducing a real-
time immunization registry could improve the system. Thirdly,
we estimated our regression models using the log of total costs
as our dependent variable. This assumes that explanatory variables
have a multiplicative effect on total costs, and that errors are nor-
mally distributed on the log scale. While this approach is conven-
tional for the type of data collected in this study [17], other
functional forms may have produced different results. As the
results of log models are difficult to interpret directly we calcu-
lated first differences to demonstrate the implications of the
regression results. Fourthly, the primary study being a cross-
sectional survey, we could only study associations between health
facility and area-level characteristics and total cost. It is not possi-
ble from current analysis to make any causal inferences.
By identifying the determinants of immunization cost in India,
this study may help policymakers to assess the impact of various
strategies on total cost. Use of pentavalent vaccine was found to
be positively associated with total facility cost including vaccine
cost. Although only two out of seven states used pentavalent vac-
cine during the study period, currently all Indian states use pen-
tavalent vaccine. This means that the total cost of the
programme has increased significantly. Pentavalent vaccine was
supported by Gavi during the study period, but that support has
ended. Further, as several new and expensive vaccines are entering
in the system (e.g., pneumococcal), total facility costs will increase
significantly. Some of these new vaccines are still Gavi supported,
but India will soon graduate from Gavi support; hence, the govern-
ment needs to ensure the additional funding that will be required.
Distance of a facility from the nearest cold chain point was signif-
icantly associated with facility cost. Currently, India’s immuniza-
tion programme operates in 26,384 cold chain points, with an
average population of 45,868 per cold chain point [18]. Increasing
the number of cold chain points and taking them closer to facilities
may help reduce vaccine delivery costs. Health facilities in wealth-
ier blocks had lower delivery costs, suggesting better access in
these blocks (both for beneficiaries and health staff) as compared
to access in the poorest blocks. This analysis therefore suggests
strategies that might improve value for money in India’s immu-
nization services.
Table 2
Results of the regression analysis of total facility cost excluding vaccine cost, for primary health centres and sub-centres.
Variable category Variables Regression coefficient (95% CI)
Fixed effects
Health facility level Log (Number of doses) 0.16 (0.072, 0.247)***
Sub-centre as compared to primary health centre 0.611 (0.799, 0.424)***
Log (distance from nearest cold chain point) 0.042 (0.003, 0.086)
Salary of the vaccinator (in units of US$1724) 0.156 (0.121, 0.191)***
Proportion of DPT3 doses in total doses 0.06 (0.335, 0.215)
Log (Number of sessions) 0.354 (0.229, 0.479)***
Block level Female literacy rate 0.007 (0, 0.013)*
% of rural population 0.003 (0.006, 0)*
% of SC/ST population 0 (0.002, 0.003)
2nd wealth quintile 0.111 (0.253, 0.031)
3rd wealth quintile 0.156 (0.321, 0.01)
4th wealth quintile 0.243 (0.484, 0.001)*
5th wealth quintile 0.173 (0.438, 0.092)
District level Health facility per 1000 children 0.022 (0.092, 0.136)
% of institutional delivery 0 (0.004, 0.004)
State-level Log (per capita income) 0.456 (0.218, 0.695)***
Variance components State 0.02545
District 0.00355
Facility 0.04235
*** Indicates p value less than 0.001.
* Indicates p value less than 0.05.
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